Silexion Therapeutics effects 1-for-15 reverse stock split, adjusts warrant terms

Silexion Therapeutics Corp

Reverse split effective after close July 28; trading on split-adjusted basis July 29 under same ticker SLXN.
Authorized shares unchanged at 1,481,482; par value increased from $0.0009 to $0.0135 per share.
Each warrant now exercisable for 1/15th of a share; exercise price adjusted to $1,552.50 per whole share.
No fractional shares will be issued; fractional interests rounded up to nearest whole share.
CUSIP for ordinary shares changed to G1281K 130; warrant CUSIP remains G1281K 114.

item 3.03item 5.03item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.